Expression of thyroid transcription factor-1 in malignant pleural effusions

Pathology and Oncology Research

Volumn 17, Issue 2, 2011, Pages 263-267

  Khoor, Andras ^c   Byrd Gloster, Angela L ^a   Nicosia, Santo V ^b  

^a Pathologists' Laboratory PC   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NONE

Author keywords

Adenocarcinoma; Cytology; Lung; Malignant mesothelioma; Pleural effusions; TTF 1

Indexed keywords

THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MALIGNANT PLEURAL EFFUSION; OVARY ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PLEURA EFFUSION; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MESOTHELIOMA; NUCLEAR PROTEINS; PLEURAL EFFUSION, MALIGNANT; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959433872     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9308-0     Document Type: Article

References (39)

1. Johnston WW (1985) The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 56:905-909 (Pubitemid 15228290)
2. Monte SA, Ehya H, Lang WR (1987) Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 31:448-452 (Pubitemid 17126855)
3. Attanoos RL, Gibbs AR (2003) 'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group Cardiff. Histopathology 43:444-452 (Pubitemid 37445235)
4. Lazzaro D, Price M, de Felice M, Di Lauro R (1991) The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113:1093-1104
5. Stahlman MT, Gray ME, Whitsett JA (1996) Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J Histochem Cytochem 44:673-678 (Pubitemid 26240774)
6. Whitsett JA, Glasser SW (1998) Regulation of surfactant protein gene transcription. Biochim Biophys Acta 1408:303-311 (Pubitemid 28517875)
7. Maeda Y, Dave V, Whitsett JA (2007) Transcriptional control of lung morphogenesis. Physiol Rev 87:219-244 (Pubitemid 46207714)
8. Katoh R, Kawaoi A, Miyagi E et al (2000) Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Mod Pathol 13:570-576 (Pubitemid 30332110)
9. Katoh R, Miyagi E, Nakamura N et al (2000) Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas. Hum Pathol 31:386-393 (Pubitemid 30161360)
10. Burke LM, Rush WI, Khoor A et al (1999) Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum Pathol 30:158-167 (Pubitemid 29086946)
11. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI et al (2000) A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 24:906-916 (Pubitemid 30430478)
12. Holzinger A, Dingle S, Bejarano PA et al (1996) Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 15:49-53 (Pubitemid 26079724)
13. Khoor A, Whitsett JA, Stahlman MT et al (1999) Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 30:695-700 (Pubitemid 29266730)
14. Folpe AL, Gown AM, Lamps LW et al (1999) Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12:5-8 (Pubitemid 29059159)
15. Byrd-Gloster AL, Khoor A, Glass LF et al (2000) Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 31:58-62 (Pubitemid 30054388)
16. Bejarano PA, Baughman RP, Biddinger PW et al (1996) Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9:445-452 (Pubitemid 26153387)
17. Moldvay J, Jackel M, Bogos K et al (2004) The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res 10:85-88 (Pubitemid 38915600)
18. Strickland-Marmol LB, Khoor A, Livingston SK, Rojiani A (2007) Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Arch Pathol Lab Med 131:1686-1690 (Pubitemid 350077466)
19. Afify AM, al-Khafaji BM (2002) Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Acta Cytol 46:675-678 (Pubitemid 34787426)
20. Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS (2001) The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 116:483-488 (Pubitemid 34450281)
21. Ng WK, Chow JC, Ng PK (2002) Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens. Cancer 96:43-48 (Pubitemid 34194319)
22. Yang GC, Wan LS, Papellas J, Waisman J (1998) Compact cell blocks. Use for body fluids, fine needle aspirations and endometrial brush biopsies. Acta Cytol 42:703-706 (Pubitemid 28274781)
23. Armitage P, Berry G, Matthews J N S (2002) Statistical Methods in Medical Research, Fourth edth edn. Blackwell Science, Oxford
24. Colby TV (2004) Adenocarcinoma. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC, Lyon, pp 35-44
25. Khoor A, Gray ME, Hull WM et al (1993) Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J Histochem Cytochem 41:1311-1319 (Pubitemid 23239095)
26. Khoor A, Gray ME, Singh G, Stahlman MT (1996) Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J Histochem Cytochem 44:1429-1438
27. Khoor A, Stahlman MT, Gray ME, Whitsett JA (1994) Temporalspatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem 42:1187-1199 (Pubitemid 24267606)
28. Khoor A, Whitsett JA, Stahlman MT et al (1997) Immunoreactivity for thyroid transcription factor-1 (TTF-1) correlates with better prognosis in early stage adenocarcinoma of the lung. Am J Respir Crit Care Med 155:A36, Abstract
29. Puglisi F, Barbone F, Damante G et al (1999) Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 12:318-324 (Pubitemid 29133854)
30. Tan D, Li Q, Deeb G et al (2003) Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol 34:597-604 (Pubitemid 36750372)
31. Weir BA, Woo MS, Getz G et al (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898 (Pubitemid 350231325)
32. Kwei KA, Kim YH, Girard L et al (2008) Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27:3635-3640 (Pubitemid 351793793)
33. Di Loreto C, Puglisi F, Di Lauro V et al (1998) TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett 124:73-78 (Pubitemid 28073811)
34. Pelosi G, Fraggetta F, Pasini F et al (2001) Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 25:363-372 (Pubitemid 32175139)
35. Ordonez NG (2003) The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27:1031-1051 (Pubitemid 36909525)
36. Motoi N, Szoke J, Riely GJ et al (2008) Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 32:810-827
37. Tsuta K, Ishii G, Nitadori J et al (2006) Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. J Pathol 209:78-87
38. Kubba LA, McCluggage WG, Liu J et al (2008) Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Mod Pathol 21:485-490 (Pubitemid 351441040)
39. Zhang PJ, Gao HG, Pasha TL et al (2009) TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol 28:10-18